Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Rosetta Stone Inc (RST): Roumell Asset Management Decreases Its Stake

A recent 13G filing with the US Securities and Exchange Commission showed that Jim Roumell‘s Roumell Asset Management has slightly decreased its stake in Rosetta Stone Inc (NYSE:RST), and currently owns 1.14 million shares, which represent almost 5.2% of the company’s outstanding stock. In its last 13F filing (for the end of 2015) Roumell Asset Management disclosed holding 1.29 million shares of Rosetta Stone (NYSE:RST).

Follow Rosetta Stone Inc (NYSE:RST)
Trade (NYSE:RST) Now!

Rosetta Stone provides brain fitness solutions, mainly a variety of language courses, which are used in schools, government organizations and a plethora of business all around the world. Over the past 12 months, the company’s shares have increased by 3.34%. Rosetta Stone (NYSE:RST) recently reported their financial results for the first quarter of 2016, and it has disclosed a loss per share of $0.34 and revenue of $48 million, beating the estimates of $0.16 and %47.1 million, respectively.

According to our database, 11 hedge funds held long positions in Rosetta Stone (NYSE:RST) at the end of December. John W. Rogers’ Ariel Investments disclosed the largest position worth about $27.7 million, and the second biggest position was reported by John H Lewis’ Osmium Partners, valued at $14.2 million. Other hedge funds long the stock were Jim Simons’s Renaissance Technologies, and Bruce Salomon’s Elberon Capital.

Among hedge funds who lost interest in this stock and sold off their positions in Rosetta Stone (NYSE:RST) during the fourth quarter were David Nierenberg’s Nierenberg Investment Management, which dropped about $10.1 million in call options, and Matthew Hulsizer’s fund, PEAK6 Capital Management also dropped its call options, around $0.1 million worth.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Roumell Asset Management 705,624 422,444 705,624 422,444 1,128,068 Approximately 5.1%
James C. Roumell ( Roumell ) 720,624 422,444 720,624 422,444 1,143,068 Approximately 5.2%

Jim Roumell
Jim Roumell
Roumell Asset Management

Page 1 of 8 – SEC Filing

Under the Securities Exchange Act of 1934
Rosetta Stone Inc.
(Name of Issuer)
Common Stock, par value $0.00005 per share
(Title of Class of Securities)
(CUSIP Number)
May 9, 2016
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
x           Rule 13d-1(b)
o           Rule 13d-1(c)
o           Rule 13d-1(d)
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).


Follow Rosetta Stone Inc (NYSE:RST)
Trade (NYSE:RST) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.